H.C. Wainwright Reiterates Maintains Galmed Pharmaceuticals (GLMD) at Neutral on Aramchol Uncertainties
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce reiterated a Neutral rating on Galmed Pharmaceuticals (NASDAQ: GLMD), following the company's Q1 report. The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
